SEARCH

SEARCH BY CITATION

References

  • 1
    Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis 2007; 14: 82.
  • 2
    Weisbord SD, Fried LF, Arnold RM, et al. Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. J Am Soc Nephrol 2005; 16: 2487.
  • 3
    Jhamb M, Weisbord SD, Steel JL, Unruh M. Fatigue in patients receiving maintenance dialysis: a review of definitions, measures, and contributing factors. Am J Kidney Dis 2008; 52: 353.
  • 4
    Ramkumar N, Beddhu S, Eggers P, Pappas LM, Cheung AK. Patient preferences for in-center intense hemodialysis. Hemodial Int 2005; 9: 281.
  • 5
    Kovacs AZ, Molnar MZ, Szeifert L, et al. Sleep disorders, depressive symptoms and health-related quality of life – a cross-sectional comparison between kidney transplant recipients and waitlisted patients on maintenance dialysis. Nephrol Dial Transplant 2011; 26: 1058.
  • 6
    Rodrigue JR, Mandelbrot DA, Hanto DW, Johnson SR, Karp SJ, Pavlakis M. A cross-sectional study of fatigue and sleep quality before and after kidney transplantation. Clin Transplant 2011; 25: E13.
  • 7
    Neipp M, Karavul B, Jackobs S, et al. Quality of life in adult transplant recipients more than 15 years after kidney transplantation. Transplantation 2006; 81: 1640.
  • 8
    Maglakelidze N, Pantsulaia T, Tchokhonelidze I, Managadze L, Chkhotua A. Assessment of health-related quality of life in renal transplant recipients and dialysis patients. Transplant Proc 2011; 43: 376.
  • 9
    Donovan KA, Jacobsen PB, Small BJ, Munster PN, Andrykowski MA. Identifying clinically meaningful fatigue with the Fatigue Symptom Inventory. J Pain Symptom Manage 2008; 36: 480.
  • 10
    Russ G, Jamieson N, Oberbauer R, et al. Three-year health-related quality-of-life outcomes for sirolimus-treated kidney transplant patients after elimination of cyclosporine. Transpl Int 2007; 20: 875.
  • 11
    Trojan DA, Arnold D, Collet JP, et al. Fatigue in multiple sclerosis: association with disease-related, behavioural and psychosocial factors. Mult Scler 2007; 13: 985.
  • 12
    Riemsma RP, Rasker JJ, Taal E, Griep EN, Wouters JM, Wiegman O. Fatigue in rheumatoid arthritis: the role of self-efficacy and problematic social support. Br J Rheumatol 1998; 37: 1042.
  • 13
    Jump RL, Robinson ME, Armstrong AE, Barnes EV, Kilbourn KM, Richards HB. Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support. J Rheumatol 2005; 32: 1699.
  • 14
    Tack BB. Fatigue in rheumatoid arthritis. Conditions, strategies, and consequences. Arthritis Care Res 1990; 3: 65.
  • 15
    Kalkman JS, Schillings ML, Zwarts MJ, van Engelen BG, Bleijenberg G. The development of a model of fatigue in neuromuscular disorders: a longitudinal study. J Psychosom Res 2007; 62: 571.
  • 16
    Voermans NC, Knoop H, van de Kamp N, Hamel BC, Bleijenberg G, van Engelen BG. Fatigue is a frequent and clinically relevant problem in Ehlers-Danlos Syndrome. Semin Arthritis Rheum 2010; 40: 267.
  • 17
    Goedendorp MM, Gielissen MF, Verhagen CA, Peters ME, Bleijenberg G. Severe fatigue and related factors in cancer patients before the initiation of treatment. Br J Cancer 2008; 99: 1408.
  • 18
    Goedendorp MM, Gielissen MF, Verhagen CA, Bleijenberg G. Development of fatigue in cancer survivors: a prospective follow-up study from diagnosis into the year after treatment. J Pain Symptom Manage 2013; 45: 213.
  • 19
    Karakoc T, Yurtsever S. Relationship between social support and fatigue in geriatric patients receiving outpatient chemotherapy. Eur J Oncol Nurs 2010; 14: 61.
  • 20
    Li Y, Yuan C. Levels of fatigue in Chinese women with breast cancer and its correlates: a cross-sectional questionnaire survey. J Am Acad Nurse Pract 2011; 23: 153.
  • 21
    Michael KM, Allen JK, Macko RF. Fatigue after stroke: relationship to mobility, fitness, ambulatory activity, social support, and falls efficacy. Rehabil Nurs 2006; 31: 210.
  • 22
    CentERdata. CentErdata Institute for data collection and research. www.centerdata.nl (last accessed 6 August 2012).
  • 23
    Dittner AJ, Wessely SC, Brown RG. The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res 2004; 56: 157.
  • 24
    Vercoulen JHMM, Alberts M, Bleijenberg G. De Checklist Individual Strength (CIS). Gedragstherapie 1999; 32: 131.
  • 25
    Vercoulen JHMM, Swanink CMA, Fennis JFM, Galama JMD, van der Meer JWM, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 1994; 38: 383.
  • 26
    Minis MA, Kalkman JS, Akkermans RP, et al. Employment status of patients with neuromuscular diseases in relation to personal factors, fatigue and health status: a secondary analysis. J Rehabil Med 2010; 42: 60.
  • 27
    Snaphaan L, van der Werf S, de Leeuw FE. Time course and risk factors of post-stroke fatigue: a prospective cohort study. Eur J Neurol 2011; 18: 611.
  • 28
    van Hoogmoed D, Fransen J, Repping-Wuts H, Spee L, Bleijenberg G, van Riel PL. The effect of anti-TNF-alpha vs. DMARDs on fatigue in rheumatoid arthritis patients. Scand J Rheumatol 2013; 42: 15.
  • 29
    Nijhof SL, Bleijenberg G, Uiterwaal CS, Kimpen JL, van de Putte EM. Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial. Lancet 2012; 379: 1412.
  • 30
    Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile – development and final revision of a health-status measure. Med Care 1981; 19: 787.
  • 31
    Jacobs HM, Luttik A, Fouw OF, de Melker RA. De ‘sickness impact profile; resultaten van een valideringsonderzoek van de Nederlandse versie [The sickness impact profile; results of an evaluation study of the Dutch version]. Ned Tijdschr Geneeskd 1990; 134: 1950.
  • 32
    Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998; 51: 1055.
  • 33
    Beck AT, Steer RA, Ball R, Ciervo CA, Kabat M. Use of the Beck Anxiety and Depression Inventories for Primary Care with medical outpatients. Assessment 1997; 4: 211.
  • 34
    Beck AT, Guth D, Steer RA, Ball R. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther 1997; 35.
  • 35
    Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory–II. San Antonio, TX: Psychological Corporation, 1996.
  • 36
    van Sonderen E. Sociale Steun Lijst–Interacties (SSL-I) en Sociale Steun Lijst–Discrepanties (SSL-D): Een handleiding. Groningen: Noordelijk Centrum voor Gezondheidsvraagstukken, 1993.
  • 37
    Cohen J. Statistical Power Analysis for the Behavioral Sciences (2nd edn). Hillsdale, New Jersey: Lawrence Erlbaum Associates, 1988.
  • 38
    Cohen J. A power primer. Psychol Bull 1992; 112: 155.
  • 39
    Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31.
  • 40
    de Groot IB, Stiggelbout AM, van der Boog PJ, Baranski AG, Marang-van de Mheen PJ, group PA-s. Reduced quality of life in living kidney donors: association with fatigue, societal participation and pre-donation variables. Transpl Int 2012; 25: 967.
  • 41
    Blokstra A, Vissink P, Venmans LMAJ, Holleman P, van der Schouw YT, Smit HA. Nederland de Maat Genomen, 2009–2010. Monitoring van risicofactoren in de algemene bevolking. RIVM-rapport nr. 260152001/2011, Bildhoven, 2011.
  • 42
    Forsberg A, Lorenzon U, Nilsson F, Backmana L. Pain and health related quality of life after heart, kidney, and liver transplantation. Clin Transplant 1999; 13: 453.
  • 43
    Perez-San-Gregorio MA, Martin-Rodriguez A, Perez-Bernal J. Influence of the psychological state of relatives on the quality of life of patients at 1 year after transplantation. Transplant Proc 2008; 40: 3109.
  • 44
    White C, Gallagher P. Effect of patient coping preferences on quality of life following renal transplantation. J Adv Nurs 2010; 66: 2550.
  • 45
    Griva K, Stygall J, Ng JH, Davenport A, Harrison MJ, Newman S. Prospective changes in health-related quality of life and emotional outcomes in kidney transplantation over 6 years. J Transplant 2011; Article ID: 671571. doi:10.1155/2011/671571.
  • 46
    Gielissen MF, Verhagen S, Witjes F, Bleijenberg G. Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: a randomized controlled trial. J Clin Oncol 2006; 24: 4882.
  • 47
    Whiting P, Bagnall AM, Sowden AJ, Cornell JE, Mulrow CD, Ramirez G. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. JAMA 2001; 286: 1360.
  • 48
    Gielissen MFM. Cognitive behaviour therapy for postcancer fatigue: a treatment protocol. In: Fatigue in Cancer Survivors: From Assessment to Cognitive Behavior Therapy. Wageningen: Ponsen & Looijen B.V., 2007: 3649.
  • 49
    Vercoulen JH, Swanink CM, Galama JM, et al. The persistence of fatigue in chronic fatigue syndrome and multiple sclerosis: development of a model. J Psychosom Res 1998; 45: 507.
  • 50
    Goedendorp MM, Peters ME, Gielissen MF, et al. Is increasing physical activity necessary to diminish fatigue during cancer treatment? Comparing cognitive behavior therapy and a brief nursing intervention with usual care in a multicenter randomized controlled trial. Oncologist 2010; 15: 1122.